APS_ACTION (@APS_ACTION) header
APS_ACTION (@APS_ACTION) profile picture

APS_ACTION

@APS_ACTION

APS ACTION is a network of internationally renown physicians & scientists working to find a cure for Antiphospholipid Syndrome or #APS

apsaction.org
Joined March 2013
  • Tweets212
  • Following78
  • Followers772
57Media
Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)Photo by APS_ACTION (@APS_ACTION)
@APS_ACTION 2025 Young Scholar Zeynep Belce Erton from @HSpecialSurgery Presenting her Research During #ICAPA25 (18th International Congress on Antiphospholipid Antibodies, Kyoto, Japan).
Image from APS_ACTION (@APS_ACTION)
2
4
537
@APS_ACTION Scientific Session and Poster Presentations During #ICAPA25 (18th International Congress on Antiphospholipid Antibodies, Kyoto, Japan). Thank you to all the presenters and session participants.
Image from APS_ACTION (@APS_ACTION)
Image from APS_ACTION (@APS_ACTION)
1
4
162
Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.
Image from APS_ACTION (@APS_ACTION)
Image from APS_ACTION (@APS_ACTION)
2
4
256
Most Recent APS ACTION Publication: pubmed.ncbi.nlm.nih.gov/4073…
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood:...

Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood:...

Our analysis of an international registry for persistently aPL-positive patients demonstrates that patients with paediatric-onset aPL-related manifestations more commonly present with non-vascular...

pubmed.ncbi.nlm.nih.gov
2
71
Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from APS ACTION. pubmed.ncbi.nlm.nih.gov/3989…
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From...

Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From...

In our cohort of persistently aPL-positive patients, the mortality rate was 5% after a median follow-up of five years and was highest for patients ≥60 years old at registry entry. History of arterial...

pubmed.ncbi.nlm.nih.gov
3
118
Survey Reveals 60% Satisfaction with DIAPS but Highlights Need for Improvements: cutt.ly/ge3C9xa4 @APS_ACTION @DorukErkanMD
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for...

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for...

Approximately 60% of respondents were satisfied with DIAPS and its definitions; however, our survey demonstrated that there is substantial room to improve the current damage index for APS. Efforts...

pubmed.ncbi.nlm.nih.gov
1
3
191
2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification c… pubmed.ncbi.nlm.nih.gov/3939…
2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome...

2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome...

2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase-based antiphospholipid antibody domain-collaborative efforts of...

pubmed.ncbi.nlm.nih.gov
92
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prosp… pubmed.ncbi.nlm.nih.gov/3818…
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome...

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome...

Fourteen percent of the TAPS patients were not anticoagulated at recruitment. Their recurrent thrombosis risk did not differ compared to matched anticoagulated TAPS patients, supporting the pressing...

pubmed.ncbi.nlm.nih.gov
1
90
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical … pubmed.ncbi.nlm.nih.gov/3942…
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the...

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the...

When we analysed aPL-positive patients with no other SARDs, ANA status was not associated with thrombosis or pregnancy morbidity. Interestingly, ANA+ patients showed higher rates of systemic autoim...

pubmed.ncbi.nlm.nih.gov
1
2
208
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and I… pubmed.ncbi.nlm.nih.gov/3966…
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for...

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for...

Approximately 60% of respondents were satisfied with DIAPS and its definitions; however, our survey demonstrated that there is substantial room to improve the current damage index for APS. Efforts...

pubmed.ncbi.nlm.nih.gov
1
2
169
HSS investigators presented new research findings in #antiphospholipidsyndrome at the @ACRheum Convergence 2024 meeting. #ACR24 #HSSRhem @DorukErkanMD @APS_ACTION news.hss.edu/new-antiphospho…
Image from Hospital for Special Surgery (HSS) (@HSpecialSurgery)
3
7
651
🤔🩸🔮 Rethinking antiphospholipid syndrome to guide future management and research @NatRevRheumatol @DorukErkanMD nature.com/articles/s41584-0…
Image from Jason S Knight (@jasonsknight)
4
31
6
77
9,757
Our most recent publication on thrombosis recurrence and major bleeding risk in non-anticoagulated thrombotic antiphospholipid syndrome patients. We want to thank all APS ACTION members for their contributions. pubmed.ncbi.nlm.nih.gov/3818…
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome...

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome...

Fourteen percent of the TAPS patients were not anticoagulated at recruitment. Their recurrent thrombosis risk did not differ compared to matched anticoagulated TAPS patients, supporting the pressing...

pubmed.ncbi.nlm.nih.gov
6
1
7
914
APS_ACTION retweeted
RPTH (@RPTHjournal) profile picture
RPTH@RPTHjournal8 Dec 2023
ICYMI: In this #RPTH Commentary @crowthrm and @DorukErkanMD discuss the new ACR/EULAR 2023 #Antiphospholipid Syndrome classification and how it may be applied across different clinical scenarios! Read here➡️: rpthjournal.org/article/S247…

A new approach to antiphospholipid antibody syndrome

Antiphospholipid antibody syndrome (APS) continues to pose challenges in clinical practice, mainly due to the multifactorial nature of thrombosis and pregnancy morbidity and the lack of reliable...

rpthjournal.org
7
14
1,584
#ACR23 Recap: @dorukerkanmd and @jasonsknight explained the antiphospholipid syndrome classification criteria developed by the ACR and EULAR. Read more in ACR Convergence Today → acr.tw/3N6aY5v
Image from American College of Rheumatology (@ACRheum)
8
1
20
2,581
Antiphospholipid Syndrome Diagnosis versus Classification. What is the Difference? The answer is in this recently updated @HSpecialSurgery Top 10 Series Patient Web Article hss.edu/conditions_top-ten-p…
Antiphospholipid Syndrome: Classification vs. Diagnosis

Antiphospholipid Syndrome: Classification vs. Diagnosis

Antiphospholipid syndrome (APS): The difference between classification criteria for medical research versus diagnosis criteria for clinical disease management.

hss.edu
35
1
78
4,964
Today we have award-winning #APS researcher @DorukErkanMD with us, who explains the importance of creating new classification criteria for APS & what the proper use of them ought to be! Listen → acronair.org #ACR23
Image from American College of Rheumatology (@ACRheum)
1
8
1
19
4,721
@APS_ACTION Core Laboratories Presented at #ACR23 Their Performance Assessment of LA Testing Using TSVT/ECT. acrabstracts.org/abstract/pe….
Image from APS_ACTION (@APS_ACTION)
1
4
194
Dr Alexander Pine Presenting at #ACR23 - @APS_ACTION & Yale School of Medicine Collaboration on Antiphospholipid Syndrome and Plasma Proteomic Profiling acrabstracts.org/abstract/pl…
Image from APS_ACTION (@APS_ACTION)
1
2
112
Dr Cecile Yelnik presenting at #ACR23 on Behalf of @APS_ACTION - Antiphospholipid Syndrome (#APS) & Complement Pathway Activation acrabstracts.org/abstract/co….
Image from APS_ACTION (@APS_ACTION)
1
6
144
Load more